Dosimetric impact of dwell time deviation constraint on inverse brachytherapy treatment planning and comparison with conventional optimization method for interstitial brachytherapy implants

被引:4
作者
Roy, Saurabh [1 ,2 ,3 ]
Subramani, V. [3 ]
Singh, Kishore [1 ]
Rathi, Arun Kumar [1 ]
机构
[1] Lok Nayak Hosp, Dept Radiotherapy, Room 123,Gate 2,Jawahar Lal Nehru Marg, Delhi 110002, India
[2] Bharathiar Univ, Res & Dev Ctr, Coimbatore, Tamil Nadu, India
[3] AIIMS, Dr BRA IRCH, Depat Radiotherapy, Delhi, India
关键词
Dwell time deviation constraint; geometric optimization; graphical optimization; inverse planning; inverse planning simulated annealing; GRAPHICAL OPTIMIZATION; TEMPLATE BRACHYTHERAPY; IR-192; IPSA;
D O I
10.4103/jcrt.JCRT_749_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: High-dose rate remote afterloading brachytherapy machine and advanced treatment planning system help in getting optimum dose to tumor and low dose to normal structures. Inverse planning simulated annealing (IPSA) optimization technique has a unique feature of dwell time deviation constraint (DTDC). In this study, six IPSA-based plans having different DTDC values with routinely practiced geometric plus graphical optimization (GO + GrO) have been compared using various dosimetric parameters. Materials and Methods: For this retrospective study, we have generated IPSA-optimized interstitial brachytherapy plans for ten cancer cervix patients. Routinely practiced GO + GrO-based plans were compared with six different IPSA plans having varying DTDC values from 0.0 to 1.0 using different dosimetric indices. Results: Conformity index and homogeneity index (HI) were higher in GO + GrO plans, compared to IPSA-optimized plans. However, HI of IPSA plans was increasing with increasing DTDC values. High-dose volumes were well controllable using DTDC parameter in IPSA-optimized plans. Dose to the rectum and bladder was smaller for IPSA-optimized plans than GO + GrO plans. Conclusions: One of the benefits of applying DTDC in IPSA-optimized plan is that it reduces high-dose volumes. Another advantage is the reduction in rectum and bladder dose.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 15 条
[1]   THE SYED-NEBLETT INTERSTITIAL TEMPLATE IN LOCALLY ADVANCED GYNECOLOGICAL MALIGNANCIES [J].
AMPUERO, F ;
DOSS, LL ;
KHAN, M ;
SKIPPER, B ;
HILGERS, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (12) :1897-1903
[2]  
Anbumani Surega, 2014, ISRN Oncol, V2014, P125020, DOI 10.1155/2014/125020
[3]   Multi-species prostate implant treatment plans incorporating 192Ir and 125I using a Greedy Heuristic based 3D optimization algorithm [J].
Chaswal, V. ;
Yoo, S. ;
Thomadsen, B. R. ;
Henderson, D. L. .
MEDICAL PHYSICS, 2007, 34 (02) :436-444
[4]  
Ghasal N, 2009, SAUDI J OBSTET GYNEC, V11, P1430
[5]   A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model [J].
Hsu, ICJ ;
Speight, J ;
Hai, J ;
Vigneault, E ;
Phillips, T ;
Pouliot, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :538-543
[6]   Comparison of IPSA with dose-point optimization and manual optimization for interstitial template brachytherapy for gynecologic cancers [J].
Jamema, Swamidas V. ;
Sharma, Smriti ;
Mahantshetty, Umesh ;
Engineer, Reena ;
Shrivastava, Shyam K. ;
Deshpande, Deepak D. .
BRACHYTHERAPY, 2011, 10 (04) :306-312
[7]   Dosimetric comparison of inverse optimization with geometric optimization in combination with graphical optimization for HDR prostate implants [J].
Jamema, Swamidas V. ;
Saju, Sherly ;
Shetty, Umesh M. ;
Pallad, Siddanna ;
Deshpande, D. D. ;
Shrivastava, S. K. .
JOURNAL OF MEDICAL PHYSICS, 2006, 31 (02) :89-94
[8]   A MULTIPLE-SITE PERINEAL APPLICATOR (MUPIT) FOR TREATMENT OF PROSTATIC, ANORECTAL, AND GYNECOLOGIC MALIGNANCIES [J].
MARTINEZ, A ;
COX, RS ;
EDMUNDSON, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (02) :297-305
[9]   A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy [J].
Morton, Gerard C. ;
Sankreacha, Raxa ;
Halina, Patrick ;
Loblaw, Andrew .
BRACHYTHERAPY, 2008, 7 (01) :12-16
[10]  
Nucletron an Elekta company EA Stockholm Sweden, 2013, ONC BRACH 4 3 PHYS A, P7